Abstract
Authors' reply to the Letter to the Editor: Lejeune et al. (2026). Unanswered questions regarding the AIR strategy in children. The Lancet (British Edition), 407(10535), 1232-1234. https://doi.org/10.1016/S0140-6736(25)02642-X, regarding their article: Hatter et al. (2025). Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial. The Lancet (British Edition), 406(10511), 1473–1483. https://doi.org/10.1016/S0140-6736(25)00861-X.